INTEGER HOLDINGS CORPORATION Debt and Equity Securities, Realized Gain (Loss)
INTEGER HOLDINGS CORPORATION (ITGR) reported Debt and Equity Securities, Realized Gain (Loss) of $550.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-23.
Financial Statements › Income Statement › Other Income
us-gaap:DebtAndEquitySecuritiesRealizedGainLoss · last filed 2026-02-23
- INTEGER HOLDINGS CORPORATION debt and equity securities, realized gain (loss) for the quarter ending 2025-12-31 was $327.00K.
- INTEGER HOLDINGS CORPORATION debt and equity securities, realized gain (loss) for the quarter ending 2025-09-26 was $50.00K, a 94.48% decline year-over-year.
- INTEGER HOLDINGS CORPORATION debt and equity securities, realized gain (loss) for the quarter ending 2024-12-31 was -$2.81M.
- INTEGER HOLDINGS CORPORATION debt and equity securities, realized gain (loss) for the quarter ending 2024-09-27 was $906.00K.
- INTEGER HOLDINGS CORPORATION debt and equity securities, realized gain (loss) for fiscal 2025 was $550.00K.
- INTEGER HOLDINGS CORPORATION debt and equity securities, realized gain (loss) for fiscal 2024 was -$780.00K.
- INTEGER HOLDINGS CORPORATION debt and equity securities, realized gain (loss) for fiscal 2023 was -$5.69M.
- INTEGER HOLDINGS CORPORATION debt and equity securities, realized gain (loss) for fiscal 2022 was -$7.64M.
| Period end | Debt and Equity Securities, Realized Gain (Loss) 3 month | Debt and Equity Securities, Realized Gain (Loss) 3 month as first filed | Debt and Equity Securities, Realized Gain (Loss) 6 month | Debt and Equity Securities, Realized Gain (Loss) 6 month as first filed | Debt and Equity Securities, Realized Gain (Loss) 9 month | Debt and Equity Securities, Realized Gain (Loss) 9 month as first filed | Debt and Equity Securities, Realized Gain (Loss) 12 month | Debt and Equity Securities, Realized Gain (Loss) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $327.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $377.00K derived: sum of 2 quarters · filed 2026-02-23 | $550.00K 10-K · filed 2026-02-23 | |||||
| 2025-09-26 | $50.00K 10-Q · filed 2025-10-23 | $223.00K 10-Q · filed 2025-10-23 | ||||||
| 2024-12-31 | -$2.81M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | -$1.91M derived: sum of 2 quarters · filed 2026-02-23 | -$780.00K 10-K · filed 2026-02-23 | |||||
| 2024-09-27 | $906.00K 10-Q · filed 2025-10-23 | $2.04M 10-Q · filed 2025-10-23 | ||||||
| 2023-12-31 | -$2.22M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | -$5.67M derived: sum of 2 quarters · filed 2026-02-23 | -$5.69M 10-K · filed 2026-02-23 | |||||
| 2023-09-29 | -$3.45M 10-Q · filed 2024-10-24 | -$3.47M 10-Q · filed 2024-10-24 | ||||||
| 2022-12-31 | -$2.02M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | -$4.91M derived: sum of 2 quarters · filed 2025-02-20 | -$7.64M 10-K · filed 2025-02-20 | |||||
| 2022-09-30 | -$2.89M 10-Q · filed 2023-10-26 | -$5.61M 10-Q · filed 2023-10-26 | ||||||
| 2021-12-31 | -$3.14M 10-K · filed 2024-02-20 | |||||||
| 2020-12-31 | $1.38M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | $3.62M derived: sum of 2 quarters · filed 2023-02-21 | $3.41M derived: sum of 3 quarters · filed 2023-02-21 | $5.34M 10-K · filed 2023-02-21 | ||||
| 2020-10-02 | $2.23M 10-Q · filed 2020-10-29 | $2.03M derived: sum of 2 quarters · filed 2020-10-29 | $3.95M 10-Q · filed 2020-10-29 | |||||
| 2020-07-03 | -$205.00K 10-Q · filed 2020-07-30 | $1.72M 10-Q · filed 2020-07-30 | ||||||
| 2019-12-31 | $191.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $1.18M derived: sum of 2 quarters · filed 2022-02-22 | -$434.00K derived: sum of 3 quarters · filed 2022-02-22 | -$475.00K 10-K · filed 2022-02-22 | $475.00K 10-K · filed 2020-02-20 | |||
| 2019-09-27 | $986.00K 10-Q · filed 2020-10-29 | -$986.00K 10-Q · filed 2019-10-31 | -$625.00K derived: sum of 2 quarters · filed 2020-10-29 | -$666.00K 10-Q · filed 2020-10-29 | $666.00K 10-Q · filed 2019-10-31 | $10.58M derived: sum of 4 quarters · filed 2021-02-18 | ||
| 2019-06-28 | -$1.61M 10-Q · filed 2020-07-30 | $1.61M 10-Q · filed 2019-08-01 | -$1.65M 10-Q · filed 2020-07-30 | $1.65M 10-Q · filed 2019-08-01 | $9.60M derived: sum of 3 quarters · filed 2021-02-18 | $9.31M derived: sum of 4 quarters · filed 2021-02-18 | ||
| 2019-03-29 | $41.00K 10-Q · filed 2019-05-03 | $11.21M derived: sum of 2 quarters · filed 2021-02-18 | $10.92M derived: sum of 3 quarters · filed 2021-02-18 | $10.63M derived: sum of 4 quarters · filed 2021-02-18 | ||||
| 2018-12-28 | $11.17M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-18 | $10.88M derived: sum of 2 quarters · filed 2021-02-18 | $10.59M derived: sum of 3 quarters · filed 2021-02-18 | $5.62M 10-K · filed 2021-02-18 | -$5.62M 10-K · filed 2019-02-22 | |||
| 2018-09-28 | -$291.00K 10-Q · filed 2019-10-31 | -$575.00K derived: sum of 2 quarters · filed 2019-10-31 | -$5.54M 10-Q · filed 2019-10-31 | |||||
| 2018-06-29 | -$284.00K 10-Q · filed 2019-08-01 | -$5.25M 10-Q · filed 2019-08-01 | ||||||
| 2018-03-30 | -$4.97M 10-Q · filed 2019-05-03 | |||||||
| 2017-12-29 | $1.56M 10-K · filed 2020-02-20 | |||||||
| 2016-12-30 | $833.00K 10-K · filed 2019-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |